# Goldbell Group: portfolio, investments and team

> Goldbell Group is a growth equity based in Singapore. 24 investments on record, latest Oct 2025. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/polaris (Millionrounds; every figure on the page links to its filing or article)

Singapore · [Investor](https://millionrounds.com/investors)

# Goldbell Group

Last cheque observed Oct 2025. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

Email

Quiet Growth equity Website unconfirmed

Debt Health Care Social Consumer Goods

Follow Goldbell Group and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fpolaris)

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 24 on record

Since the last cheque **390** days **00** hrs **00** min **00** sec

Median round **$38M** Rounds led **0 of 24** Mostly in **United States, 92%**

Pitch Goldbell Group

Another investor of this name exists, and we could not establish from the rounds which of them the press meant. Treat the record below as possibly belonging to either. [Tell us which](https://millionrounds.com/corrections?slug=polaris) if you know.

## Goldbell Group highlights

- 01 24 rounds on record
- 02 Mostly Series B and Series C: 65% of its rounds

## What they do

- **Type:** Growth equity (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Debt
- **Sectors:** Health Care Social Consumer Goods
- **Based in:** Singapore, Singapore
- **Cold pitches:** Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. [Tell us the right one](https://millionrounds.com/corrections?slug=polaris).

## The record

Every round we can evidence, newest first **24 appearances**

- **2025** 1 round
- **Oct** **[Takenos](https://millionrounds.com/company/takenos)** Seed · AR · LatamList **$5.0M** With 10 others
- **2019** 3 rounds
- **Oct** **Waycare** Series A · IL · VentureBeat **$7.3M** With 7 others
- **Sept** **[Faraday Pharmaceuticals](https://millionrounds.com/company/faraday-pharmaceuticals)** US · GeekWire **$25M** With 1 other
- **Jan** **[Frequency Therapeutics](https://millionrounds.com/company/frequency-therapeutics)** Series B · US · FinSMEs **$42M** With 6 others
- **2018** 11 rounds
- **Dec** **[Kallyope](https://millionrounds.com/company/kallyope)** Series B · US · FinSMEs **$21M** With 6 others
- **Nov** **[ClearSky Data](https://millionrounds.com/company/clearsky-data)** US · FinSMEs **$20M** With 2 others
- **Sept** **[Lyra Therapeutics](https://millionrounds.com/company/lyra-therapeutics)** Series B · US · FinSMEs **$30M** With 5 others
- **Aug** **[Twistlock](https://millionrounds.com/company/twistlock)** Series C · US · FinSMEs **$33M** With 4 others
- **Aug** **[SQZ Biotechnologies](https://millionrounds.com/company/sqz-biotechnologies)** Series C · US · FinSMEs **$72M** With 10 others
- **Jul** **[Gossamer Bio](https://millionrounds.com/company/gossamer-bio)** Series B · US · Biospace **$230M** With 4 others
- **Jul** **[AgBiome](https://millionrounds.com/company/agbiome)** Series C · US · FinSMEs **$65M** With 5 others
- **Jun** **[Falkonry](https://millionrounds.com/company/falkonry)** Series A · US · FinSMEs **$4.6M** With 4 others
- **May** **[Iora Health](https://millionrounds.com/company/iora-health)** Series E · US · FinSMEs **$100M** With 7 others
- **Feb** **[Kallyope](https://millionrounds.com/company/kallyope)** Series B · US · FinSMEs **$66M** With 6 others
- **Jan** **[Pony.ai](https://millionrounds.com/company/pony-ai)** Series A · US · FinSMEs **$112M** With 9 others
- **2017** 9 rounds
- **Dec** **[Jnana](https://millionrounds.com/company/jnana)** Series A · US · FinSMEs **$50M** With 4 others
- **Dec** **[Metacrine](https://millionrounds.com/company/metacrine)** Series B · US · FinSMEs **$22M** With 3 others
- **Oct** **[Visterra](https://millionrounds.com/company/visterra)** Series C · US · FinSMEs **$47M** With 5 others
- **Jun** **[FloQast](https://millionrounds.com/company/floqast)** Series B · US · FinSMEs **$25M** With 1 other
- **Jun** **[Neuronetics](https://millionrounds.com/company/neuronetics)** Series G · US · FinSMEs **$15M** With 11 others
- **Jun** **[Lob](https://millionrounds.com/company/lob)** Series B · US · FinSMEs **$20M** With 2 others
- **Apr** **[Arsanis](https://millionrounds.com/company/arsanis)** Series D · US · FinSMEs **$46M** With 6 others
- **Mar** **[Freenome](https://millionrounds.com/company/freenome)** Series A · US · FinSMEs **$65M** With 7 others
- **Jan** **[Scholar Rock](https://millionrounds.com/company/scholar-rock)** Series C · US · FinSMEs **$47M** With 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## What they claim to have backed

From their own portfolio page (on their website)

**3** of 7 we have independently watched raise

[Pilon](https://millionrounds.com/company/pilon)[SWAT Mobility](https://millionrounds.com/company/swat-mobility)[Xsquaretechnologies](https://millionrounds.com/company/xsquare-technologies) BlueSG Emmasg Financing Gbcare

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

## The cheque

Debt

Median round joined **$38M** the round, not its cheque

Led 0 of 24 rounds **0%**

- **Sole investor:** Never alone
- **Last cheque:** Oct 2025

Rounds by stage said on their site

- Series B *8*
- Series C *5*
- Series A *5*
- Seed *1*
- Series D *1*
- Debt said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 5
- [Arch](https://millionrounds.com/fund/arch) 3
- [Illumina](https://millionrounds.com/fund/illumina) 3
- [Euclidean Capital](https://millionrounds.com/fund/euclidean-capital) 2
- [Fidelity](https://millionrounds.com/fund/fidelity) 2
- [GE](https://millionrounds.com/fund/ge) 2

**Pitching Goldbell Group?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Goldbell Group. A count of rooms they were both in, not a relationship either has claimed.

[**Alexandria Real Estate Equities** VC firm **5** rounds together](https://millionrounds.com/fund/alexandria)[**Arch** Hedge fund **3** rounds together](https://millionrounds.com/fund/arch)[**Illumina** Company **3** rounds together](https://millionrounds.com/fund/illumina)[**Euclidean Capital** Family office **2** rounds together](https://millionrounds.com/fund/euclidean-capital)[**Fidelity** VC firm **2** rounds together](https://millionrounds.com/fund/fidelity)[**GE** Corporate VC **2** rounds together](https://millionrounds.com/fund/ge)[**Google Ventures** Corporate VC **2** rounds together](https://millionrounds.com/fund/gv)[**Omega Funds** VC firm **2** rounds together](https://millionrounds.com/fund/omega-funds)[**The Column Group** VC firm **2** rounds together](https://millionrounds.com/fund/the-column-group)[**Two Sigma** VC firm **2** rounds together](https://millionrounds.com/fund/two-sigma)

## Recently backed

The latest companies Goldbell Group put money into.

[**Takenos** $5.0M · Oct 2025](https://millionrounds.com/company/takenos)[**Faraday Pharmaceuticals** $25M · Sept 2019](https://millionrounds.com/company/faraday-pharmaceuticals)[**Frequency Therapeutics** $42M · Jan 2019](https://millionrounds.com/company/frequency-therapeutics)[**Kallyope** $21M · Dec 2018](https://millionrounds.com/company/kallyope)[**Lyra Therapeutics** $30M · Sept 2018](https://millionrounds.com/company/lyra-therapeutics)[**Gossamer Bio** $230M · Jul 2018](https://millionrounds.com/company/gossamer-bio)

## Quick answers about Goldbell Group

### What does Goldbell Group invest in?

Goldbell Group invests most often at Series B and Series C (65% of the rounds on record), in sectors such as Health Care, Social and Consumer Goods.

### How active is Goldbell Group?

24 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2025.

### What has Goldbell Group invested in recently?

Its most recent investments on record: Takenos (Seed, Oct 2025), Waycare (Series A, Oct 2019) and Faraday Pharmaceuticals (Undisclosed round, Sept 2019).

### How big are Goldbell Group's cheques?

The median round it joins is $38M.

### Does Goldbell Group lead rounds?

Rarely, if at all: none of its 24 investments on record names it as the lead.

### Where does Goldbell Group invest?

Most of the companies it backs are in the United States (92%).

### Is Goldbell Group investing now?

No investments in the last 12 months; the latest was in Oct 2025.

### Who does Goldbell Group invest alongside?

Most often Alexandria Real Estate Equities (5 rounds together), Arch (3 rounds together) and Illumina (3 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=polaris) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=polaris)